Evidence map›Paper›PMID 25833696›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

Decreased expression of RPS15A suppresses proliferation of lung cancer cells.

Xinmin Zhao, Lei Shen, Yu Feng, Hui Yu, Xianghua Wu, Jianhua Chang, Xuxia Shen, Jie Qiao, Jialei Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Ribosome heterogeneity in development and disease.Frontiers in cell and developmental biology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Down-regulation of ribosomal protein S15A inhibits proliferation of human glioblastoma cells in vivo and in vitro via AKT pathway.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xinmin ZhaoDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Lei ShenDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Yu FengDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Hui YuDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Xianghua WuDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Jianhua ChangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Xuxia ShenDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Jie QiaoDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Jialei WangDepartment of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. wangjialeiMD@163.com.
Fudan University Shanghai Cancer Center · CNShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is the leading cause of cancer-related death in the world. Previous report has identified ribosomal protein s15a (RPS15A) as a TGF-β-responsible gene in the lung adenocarcinoma cell line A549. In this study, we used specific si-RNA to downregulate RPS15A expression in A549 cells and found that decreased RPS15A expression significantly inhibited cell proliferation and survival, as determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and colony formation assays. Moreover, A549 cells were obviously accumulated in the G0/G1 phase in response to RPS15A knockdown, suggesting that RPS15A inhibition could induce a diminution of proliferation through cell cycle arrest. In addition, immunohistochemistry analysis further revealed that RPS15A was overexpressed in surgically resected lung cancer tissues. In conclusion, we identify RPS15A as a novel potential oncogenic gene involved in lung carcinogenesis. This study may provide a preliminary experimental basis for a gene therapy approach for treating lung cancer.

Indexed as

AdenocarcinomaAdenocarcinoma of LungAgedApoptosisCell Cycle CheckpointsCell Line, TumorCell ProliferationCell SurvivalFemaleGene Expression Regulation, NeoplasticHumansLung NeoplasmsMaleMiddle AgedRibosomal ProteinsTransforming Growth Factor betaRibosomal Proteinsribosomal protein S15aTransforming Growth Factor betaLung cancerProliferationRPS15Asi-RNA

Identifiers

PMID25833696
OpenAlexW2048695114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.